最新消息最新消息

**人工智能医疗科技公司Carlsmed完成5250万美元C轮融资**

近日,全球领先的人工智能个性化手术医疗科技公司Carlsmed宣布,已成功完成由B Capital和US Venture Partners共同领投的5250万美元C轮融资。此轮融资的注入,标志着Carlsmed在医疗科技领域的创新与发展迈出了重要一步。

Carlsmed表示,筹集的资金将主要用于aprevo ®个性化脊柱手术平台的商业化进程,尤其是针对腰椎融合手术的应用。此外,这笔资金还将加速aprevo ®在颈椎融合手术领域的研发,预计该平台将于2025年正式推出。aprevo ®平台的创新技术,旨在通过人工智能实现手术的精准化和个性化,以提高手术成功率并减少患者康复时间。

此次B Capital和US Venture Partners的联合投资,彰显了资本市场对Carlsmed技术潜力和市场前景的高度认可。Carlsmed的先进技术有望重塑脊柱手术的标准,为全球医疗行业带来革命性的变化。

随着医疗科技的飞速发展,人工智能在医疗领域的应用越来越广泛。Carlsmed的融资成功,不仅为其自身的发展提供了强大的资金支持,也为人工智能在手术医疗领域的广泛应用开辟了新的道路。

英语如下:

**News Title:** “Carlsmed Raises $52.5 Million in Series C Funding to Accelerate Commercialization of Personalized Spine Surgery Technology”

**Keywords:** Carlsmed, Artificial Intelligence, Surgical Platform

**News Content:**

Artificial intelligence (AI) medical technology company Carlsmed has recently announced the successful completion of a $52.5 million Series C funding round, led by B Capital and US Venture Partners. This financing milestone marks a significant step forward in Carlsmed’s innovation and growth within the medical technology sector.

The funds raised will primarily support the commercialization of the aprevo ® personalized spine surgery platform, particularly for its application in lumbar fusion surgeries. Furthermore, the capital will expedite the platform’s development for cervical fusion procedures, with an anticipated launch in 2025. The aprevo ® platform, leveraging AI, aims to enhance surgical precision and personalization, thereby increasing surgical success rates and reducing patient recovery times.

The joint investment by B Capital and US Venture Partners underscores the capital market’s high regard for Carlsmed’s technological potential and market prospects. The company’s advanced technology has the potential to redefine standards in spinal surgery and bring about a transformative change in the global healthcare industry.

As medical technology advances rapidly, AI’s application in healthcare is becoming increasingly prevalent. Carlsmed’s successful funding not only bolsters its financial foundation but also paves the way for broader adoption of AI in surgical medicine.

【来源】https://www.businesswire.com/news/home/20240318820510/en/Carlsmed-Raises-52.5M-in-Series-C-Financing-to-Advance-Personalized-Spine-Surgery

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注